The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor.
published in: Journal of Molecular Neuroscience
date of publication: 2008-07-03
Cites articles 11
- 1999-11-01
Date
Title
Article - wd:Q46505277